FDA Approved Products
553 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
Pre-Launch
TOPICAL · CREAM
NDA
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
Pre-Launch
TOPICAL · OINTMENT
NDA
BETAMETHASONE VALERATE
betamethasone valerate
Pre-Launch
TOPICAL · CREAM
NDA
BETAMETHASONE VALERATE
betamethasone valerate
Pre-Launch
TOPICAL · OINTMENT
NDA
BETAMETHASONE VALERATE
betamethasone valerate
Pre-Launch
TOPICAL · LOTION
NDA
BETAPAR
meprednisone
Pre-Launch
Merck & Co.
ORAL · TABLET
NDA
BICILLIN
penicillin g benzathine
Pre-Launch
Thayer Medical
ORAL · TABLET
the treatment of infections due to penicillin-G-sensitive microorganismsvery prolonged serum levels common to this particular dosage form
NDA
BORTEZOMIB
bortezomib
Pre-Launch
Teva
INJECTION · INJECTABLE
myelomalymphoma
NDA
BRANCHAMIN 4%
amino acids
Pre-Launch
Baxter
INJECTION · INJECTABLE
NDA
BRETHAIRE
terbutaline sulfate
Pre-Launch
Novartis
INHALATION · AEROSOL, METERED
asthma
NDA
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
bretylium tosylate
Pre-Launch
Baxter
INJECTION · INJECTABLE
NDA
BRETYLOL
bretylium tosylate
Pre-Launch
Pfizer
INJECTION · INJECTABLE
NDA
BRONKOMETER
isoetharine mesylate
Pre-Launch
Sanofi
INHALATION · AEROSOL, METERED
NDA
BRONKOSOL
isoetharine hydrochloride
Pre-Launch
Sanofi
INHALATION · SOLUTION
NDA
BRYREL
piperazine citrate
Pre-Launch
Sanofi
ORAL · SYRUP
NDA
CABAZITAXEL
cabazitaxel
Pre-Launch
Novartis
INTRAVENOUS · SOLUTION
combination with prednisone for treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimenprostate cancer
NDA
CABAZITAXEL
cabazitaxel
Pre-Launch
Fresenius Kabi
INJECTION · INJECTABLE
combination with prednisone for treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimenprostate cancer
NDA
CALCIMAR
calcitonin salmon
Pre-Launch
Sanofi
INJECTION · INJECTABLE
symptomatic Paget's disease of bone in patients with moderate to severe disease characterized by polyostotic involvement with elevated serum alkaline phosphataseurinary hydroxyproline excretion+2
NDA
CALCIPARINE
heparin calcium
Pre-Launch
Sanofi
INJECTION · INJECTABLE
NDA
CALCIUM GLUCEPTATE
calcium gluceptate
Pre-Launch
Eli Lilly and Company
INJECTION · INJECTABLE
NDA
CAMOQUIN HYDROCHLORIDE
amodiaquine hydrochloride
Pre-Launch
Pfizer
ORAL · TABLET
NDA
CANDEX
nystatin
Pre-Launch
R-Pharm US
TOPICAL · LOTION
infections of the oral cavity caused by Candida albicans
SMNDA
CARDIOQUIN
quinidine polygalacturonate
Pre-Launch
ORAL · TABLET
NDA
CARDRASE
ethoxzolamide
Pre-Launch
Pfizer
ORAL · TABLET
NDA